Boehringer Ingelheim Takeover Of Japan's SS Pharmaceutical Subsidiary
This article was originally published in PharmAsia News
Executive Summary
Boehringer Ingelheim announced Feb. 10 a plan to acquire all outstanding shares ofJapan's third largest over-the-counter drug maker SS Pharmaceutical